Advances in necrotizing enterocolitis

Jornal de Pediatria

Volumn 81, Issue 1 SUPPL. 1, 2005, Pages

  De Oliveira, Nelson Diniz ^a,b,e   Miyoshi, Milton Harumi ^c,d  

^a Escola Superior de Ciências da Saúde SES   (Brazil)

^b Hospital Santa Lucia   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Hospital e Maternidade Santa Joana   (Brazil)

^e NONE   (Brazil)

Author keywords

Necrotizing enterocolitis; Prematurity; Short bowel syndrome

Indexed keywords

ANTIBIOTIC AGENT; ARGININE; CORTICOSTEROID; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN; NITRIC OXIDE; PREBIOTIC AGENT; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTIFICIAL MILK; BREAST FEEDING; BREAST MILK; CELL REGENERATION; CORTICOSTEROID THERAPY; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; GASTROINTESTINAL TRACT; HUMAN; INTRAUTERINE GROWTH RETARDATION; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; PARENTERAL NUTRITION; PATENT DUCTUS ARTERIOSUS; PATHOGENESIS; PATHOPHYSIOLOGY; PERINATAL ASPHYXIA; PREMATURITY; PRENATAL PERIOD; REVIEW; RISK FACTOR; SMALL INTESTINE; NEWBORN; VERY LOW BIRTH WEIGHT;

ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT;

EID: 27744542935     PISSN: 00217557     EISSN: 00217557     Source Type: Journal    
DOI: 10.1590/s0021-75572005000200003     Document Type: Review

References (78)

1. Israel EJ. Neonatal necrotizing enterocolitis, a disease of the immature intestinal mucosa barrier. Acta Paediatr Suppl. 1994;396:27-32.
2. Kliegman RM, Fanaroff AA. Neonatal necrotizing enterocolitis: a nine year experience: epidemiology and uncommon observations. Am J Dis Child. 1981;135:603-10.
3. Gamarra E, Helardot P, Morriete G. Necrotizing enterocolitis in full-term neonates. Biol Neonate. 1983;44:185-8.
4. Wilson R, del Portillo M, Schimidt E. Risk factors for necrotizing enterocolitis in infants weighing more than 2000 g at birth: a case control study. Pediatrics. 1983;71:19-25.
5. Kafetzis DA, Skevaki C, Costalos C. Neonatal necrotizing enterocolitis: an overview. Curr Opin Infect Dis. 2003;16:349-55.
6. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, et al. Very low birth weight outcomes of National Institute of Child Health and Human Development neonatal research network. January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics. 2001;107:E1-8.
7. Zaw W, Gagnon R, da Silva O. The risk of adverse neonatal outcome among preterm small for gestational age infants according to neonatal versus fetal growth standards. Pediatrics. 2003;111:1273-7.
8. Dykes EH, Gilmour WH, Azmy AF. Prediction of outcome following necrotizing enterocolitis in a neonatal surgical unit. J Pediatr Surg. 1985;20:2-6.
9. Vieira MT, Lopes JM. Fatores associados à enterocolite necrosante. J Pediatr (Rio J). 2003;79:159-64.
10. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33:179-84.
11. Leonidas JC, Hall RT. Neonatal pneumatosis coli: a mild form of neonatal necrotizing enterocolitis. J Pediatr. 1976;89:456-9.
12. Barnard JA, Cotton RB, Lutin W. Necrotizing enterocolitis. Variables associated with severity of disease. Am J Dis Child. 1985;139:375-80.
13. Buch NA, Ahmad SM, Ali SW, Hassan HM. An epidemiological study of neonatal necrotizing enterocolitis. Saudi Med J. 2001;22:231-7.
14. Schettini ST, Miyoshi MH. Enterocolite necrosante neonatal. Pediatria Moderna. 1999;35:145-58.
15. Stevenson DK, Kerner JA, Malachowski N, Sunshine P. Late morbidity among survivors of necrotizing enterocolitis. Pediatrics. 1980;66:925-7.
16. Kliegman R, Fanaroff A. Neonatal necrotizing enterocolitis. N Engl J Med. 1984;310:1093-103.
17. Ng S. Necrotizing enterocolitis in the full-term neonates. J Paediatr Child Health. 2001;37:1-4.
18. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction: the Vermont Oxford Network. Am J Obstet Gynecol. 2000;182:198-206.
19. Hallstrom M, Koivisto AM, Janas M, Tammela O. Frequency of risk factors for necrotizing enterocolitis in infants born before 33 weeks of gestation. Acta Paediatr. 2003;92:111-13.
20. Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol. 2004;191:481-7.
21. McMillen IC, Adams MB, Ross JT, Coulter CL, Simonetta G, Owens JA, et al. Fetal growth restriction: adaptations and consequences. Reproduction. 2001;122:195-204.
22. Kempley ST, Gamsu HR, Vyas S, Nicolaides K. Effects of intrauterine growth retardation on postnatal visceral and cerebral blood flow velocity. Arch Dis Child. 1991;66:1115-18.
23. Mandel D, Lubetzky R, Mimouni FB, Cohen S, Littner Y, Deutsch V, et al. Nucleated red blood cells in preterm infants who have necrotizing enterocolitis. J Pediatr. 2004;144:653-5.
24. Burrin DG, Stoll B. Key nutrients and growth factors for neonatal gastrointestinal tract. Clin Perinatal. 2002;29:65-96.
25. Payne D, Kubes P. Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol. 1993;265:G189-95.
26. Caplan MS, Hedlund E, Hill N, MacKendrick W. The role of endogenous nitric oxide and platelet activating factor in hypoxia-induced intestinal injury in rats. Gastroenterol. 1993;28:149-54.
27. Kubes P. Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol. 1993;264:G143-9.
28. Zamora SA, Amin HJ, McMillan DD, Kubes P, Fick GH, Butzner JD, et al. Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis. J Pediatr. 1997;131:226-32.
29. Becker RM, Wu G, Galanko JA, Chen W, Maynor AR, Bose CL, et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr. 2000;137:785-93.
30. Di Lorenzo M, Bass J, Krantis A. Use of L-arginine in the treatment of experimental necrotizing enterocolitis. J Pediatr Surg. 1995;30:235-40.
31. Akisu M, Ozmen D, Baka M, Habif S, Yalaz M, Arslanoglu S, et al. Protective effect of dietary supplementation with L-arginine and L-carnitine on hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Biol Neonate. 2002;81:260-5.
32. Amin HJ, Zamora SA, McMillan DD, Fick GH, Butzner JD, Parsons HG, et al. Arginine supplementation prevents necrotizing enterocolitis in premature infant. J Pediatr. 2002;140:425-31.
33. Sullivan PB, Brueton MJ, Tabar ZB, Goodlad RA, Lee CY, Wright NA. Epidermal growth factor in necrotizing enteritis. Lancet. 1991;338:53-4.
34. Scott SM, Rogers C, Angelus P, Backstrom C. Effect of necrotizing enterocolitis on urinary epidermal growth factor levels. Am J Dis Chil. 1991;145:804-7.
35. Helmrath MA, Shin CE, Fox JW, Erwin CR, Warner BW. Epidermal growth factor in saliva and serum of infants with necrotizing enterocolitis. Lancet. 1998;351:266-7.
36. Shin CE, Falcone Jr RA, Stuart L, Erwin CR, Warner BW. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg. 2000;35:173-6.
37. Wong W, Wright NA. Epidermal growth factor, epidermal growth factor receptors, intestinal growth and adaptation. J Parenter Enteral Nutr. 1999;23:S83-8.
38. Kosloske AM. Indications for operation in necrotizing enterocolitis revisited. J Pediatr Surg. 1994;29:663-6.
39. Erlich PF, Sato TT, Short BL, Hartman GE. Outcome of perforated necrotizing enterocolitis in the very-low-birth weight neonate may be independent of the type of surgical treatment. Am Surg. 2001;67:752-6.
40. Moss RL, Dimmitt RA, Henry MC, Geraghty N, Efron B. A meta-analysis of peritoneal drainage versus laparotomy for perforated necrotizing enterocolitis. J Pediatr Surg. 2001;36:1210-13.
41. Moss RL. A randomized trial of primary drainage versus laparotomy and bowel resection for treatment of perforated necrotizing enterocolitis in premature infants. R01 HD 38462-01A1, Bethesda (MD): NIH/NICHD; 2004.
42. Porus R. Epithelial hyperplasia following massive bowel resection in man. Gastroenterol. 1965;48:753-7.
43. Williamson RC. Intestinal adaptation (second of two parts). Mechanisms of control. N Engl J Med. 1978;298:1444-50.
44. Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, DiCanzio J, Richardson DS, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr. 2001;139:27-33.
45. Goulet OJ, Revillon Y, Jan D, De Potter S, Maurage C, Lortat-Jacob S, et al. Neonatal short bowel syndrome. J Pediatr. 1991;119:18-23.
46. Mayr JM, Schober PH, Weissensteiner U, Hollwarth ME. Morbidity and mortality of the short-bowel syndrome. Eur J Pediatr Surg. 1999;9:231-5.
47. Bohnhorst B, Muller S, Dordelmann M, Peter CS, Petersen C, Poets CF. Early feeding after necrotizing enterocolitis in preterm infants. J Pediatr. 2003;143:484-7.
48. Quirós-Tejeira RE, Ament ME, Reyen L, Herzog F, Merjanian M, Olivares-Serrano N, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25 year experience. J Pediatr. 2004;145:157-63.
49. Bauer Cr, Morrison JC, Poole WK, Korones SB, Boehm JJ, Rigatto H, et al. A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics. 1984;73:682-8.
50. Halac E, Halac J, Begue EF, Casanas JM, Indiveri DR, Petit JF, et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr. 1990;117:132-8.
51. Smith LM, Qureshi N, Chao CR. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less 30 weeks gestation. J Matern Fetal Med. 2000;9:131-5.
52. Kamisuka MD, Horton HK, Williams MA. The incidence of necrotizing enterocolitis after introducing standardized feeding schedules for infants between 1250 and 2500g and less 35 weeks of gestation. Pediatrics. 2000;105:379-84.
53. Guthrie SO, Gordon PV, Thomas V, Thorp JA, Peabody J, Clark RH. Necrotizing enterocolitis among neonates in the United States. J Perinatol. 2003;23:278-85.
54. Ryder RW, Shelton JD, Guinan ME. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol. 1980;112:113-23.
55. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoi G, et al. A randomized controlled trial of very early prophylatic ligation of the ductus arteriosus in babies who weighed 1000g or less at birth. N Engl J Med. 1989;320:1511-16.
56. Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2003;88:F464-6.
57. Grosfeld JL, Chaet M, Molinari F, Engle W, Engum SA, West KW, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg. 1996;224:350-5.
58. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciuili D, Rubaltelli F. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr. 1999;135:733-8.
59. O'Donovan DJ, Baetiong A, Adams K, Chen A, Smith EO, Adams JM, et al. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. J Perinatol. 2003;23:286-90.
60. Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2003;(2):CD003745.
61. Egan EA, Mantilla G, Nelson RM, Eitzman DV. A prospective controlled trial of oral kanamycin in the prevention of neonatal necrotizing enterocolitis. J Pediatr. 1976;89:467-70.
62. Boyle R, Nelson JS, Stonestreet BS, Peter G, Oh W. Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis. J Pediatr. 1978;93:857-61.
63. Rowley MP, Dahlenburg GW. Gentamicin prophylaxis of neonatal necrotizing enterocolitis. Lancet. 1978;2:532.
64. Siu YK, Ng PC, Fung SC, Lee CH, Wong MY, Fok YF, et al. Double blind, randomized, placebo controlled study of oral vancomycin in prevention of necrotizing enterocolitis in preterm, very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 1998;79:F105-9.
65. Bury RG, Tudehope D. Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev. 2001;(1):CD000405.
66. Eibl MM, Wolf HM, Furnkranz H, Rosenkranz A. Prevention of necrotizing enterocolitis in low birth-weight infants by IgA-IgG feeding. N Engl J Med. 1988;319:1-7.
67. Rubaltelli FF, Benini F, Sala M. Prevention of necrotizing enterocolitis in neonates at risk by oral administration of monomeric IgG. Dev Pharmacol Ther. 1991;17:138-43.
68. Foster J, Cole M. Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birthweight neonates. Cochrane Database Syst Rev. 2004;(1):CD001816.
69. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low birthweight infants. Cochrane Database Syst Rev. 2004;(1):CD000361.
70. Crissing KD. Regulation of hemodynamics and oxygenation in developing intestine: insight into the pathogenesis of necrotizing enterocolitis. Acta Paediatr Suppl. 1994;396:8-10.
71. Nowicki P. Intestinal ischemia and necrotizing enterocolitis. J Pediatr. 1990;117:S14-19.
72. Barlow B, Santulli TV, Heird WC, Pitt J, Blanc WA, Schullinger JN. An experimental study of acute neonatal enterocolitis: the importance of breast milk. J Pediatr Surg. 1974;9:587-95.
73. Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics. 1999;103:1150-7.
74. Lucas A, Cole TJ. Breast milk and neonatal necrotizing enterocolitis. Lancet. 1990;336:1519-23.
75. Reber K, Nankervis CA. Necrotizing enterocolitis: preventive strategies. Clin Perinatol. 2004;31:157-67.
76. Caplan MS, Lickerman M, Adler L, Dietsch G, Yu A. The role of recombinant platelet-activating factor acethylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res. 1997;42:779-83.
77. Caplan MS, Sun XM, Hseuh W, Hageman JR. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr. 1990;116:960-4.
78. McGuire W, Anthony MY. Donor human milk versus formula for preventing necrotizing enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed. 2003;88:F11-14.